ADMA Biologics (ADMA) Hit With Federal Securities Lawsuit Over Revenue Inflation Allegations

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 8 hours ago

Micron makes a statement with the latest clue about its cash windfall

A new disclosure about Micron’s buyback plans appears meant to show shareholders that Micron is more generous with cash than one of its key rivals, an analyst said.

MarketWatch

marketsabout 11 hours ago

This five-star money manager shares three stock picks, including one betting on dying American malls

One highly rated fund manager shares some top picks, including two names many U.S. investors will be unfamiliar with.

MarketWatch

marketsabout 12 hours ago

Nobel prize in economics awarded to Robert E. Hall and Michael Woodford

The U.S. economists were awarded for work that underpins the models used by central banks and governments to stabilize the economy.

CNBC Markets